GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 289 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,087,000 | +88.4% | 9,622 | +0.2% | 0.00% | – |
| Q4 2020 | $1,108,000 | +33.5% | 9,603 | +12.8% | 0.00% | – |
| Q3 2020 | $830,000 | -15.7% | 8,510 | +6.2% | 0.00% | – |
| Q2 2020 | $984,000 | +120.6% | 8,014 | +57.7% | 0.00% | – |
| Q1 2020 | $446,000 | +17.1% | 5,082 | +39.3% | 0.00% | – |
| Q4 2019 | $381,000 | +556.9% | 3,648 | +619.5% | 0.00% | – |
| Q3 2019 | $58,000 | -19.4% | 507 | +20.7% | 0.00% | – |
| Q2 2019 | $72,000 | +188.0% | 420 | +181.9% | 0.00% | – |
| Q1 2019 | $25,000 | +78.6% | 149 | 0.0% | 0.00% | – |
| Q4 2018 | $14,000 | -48.1% | 149 | -5.7% | 0.00% | – |
| Q3 2018 | $27,000 | +22.7% | 158 | 0.0% | 0.00% | – |
| Q2 2018 | $22,000 | – | 158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 3,455,054 | $456,102,000 | 8.18% |
| Consonance Capital Management LP | 675,492 | $89,172,000 | 8.05% |
| Prisma Capital Partners LP | 33,000 | $4,356,000 | 4.11% |
| Broadfin Capital, LLC | 122,930 | $16,228,000 | 2.65% |
| Rock Springs Capital Management LP | 354,000 | $46,732,000 | 2.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 339,180 | $44,775,000 | 1.76% |
| GREAT POINT PARTNERS LLC | 75,000 | $9,901,000 | 1.69% |
| Atika Capital Management LLC | 31,000 | $4,092,000 | 1.58% |
| Sivik Global Healthcare LLC | 30,000 | $3,960,000 | 1.47% |
| Sio Capital Management, LLC | 19,000 | $2,508,000 | 1.41% |